The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy-Reference-Cited by-同舟云学术

The CXCL12 (SDF-1)/CXCR4 chemokine axis: Oncogenic properties, molecular targeting, and synthetic and natural product CXCR4 inhibitors for cancer therapy

Published:2018-11 Issue:11 Volume:16 Page:801-810
ISSN:1875-5364
Container-title:Chinese Journal of Natural Medicines
language:en
Short-container-title:Chinese Journal of Natural Medicines

Author:

ZHOU Yu,CAO Han-Bo,LI Wen-Jun,ZHAO Li

Funder

National Natural Science Foundation of China

Science Foundation for Distinguished Young Scholars of Jiangsu Province

National Science and Technology Major Project

Project Program of State Key Laboratory of Natural Medicines, China Pharmaceutical University

Program for Changjiang Scholars and Innovative Research Team in University

Open Project of State Key Laboratory Cultivation Base for TCM Quality and Efficacy, Nanjing University of Chinese Medicine

Publisher

Elsevier BV

Subject

Complementary and alternative medicine,Drug Discovery,General Medicine

Reference100 articles.

1. Cloning of a human seven-transmembrane domain receptor, LESTR, that is highly expressed in leukocytes [J];Loetscher;J Biol Chem,1994

2. Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma [J];Duan;Oncol Lett,2016

3. CXCL12/CXCR4 axis upregulates twist to induce EMT in human glioblastoma [J];Yao;Mol Neurobiol,2016

4. SDF-1/CXCR4 signaling up-regulates survivin to regulate human sacral chondrosarcoma cell cycle and epithelial-mesenchymal transition via ERK and PI3K/AKT pathway [J];Yang;Med Oncol,2015

5. CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis [J];Sun;Mol Cancer Ther,2013

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of SDF-1/CXCR4 and related inflammatory factors in sodium fluoride-treated hepatocytes;PLOS ONE;2024-06-21

2. Re-exploration of immunotherapy targeting EMT of hepatocellular carcinoma: Starting from the NF-κB pathway;Biomedicine & Pharmacotherapy;2024-05

3. A promising strategy of surface-modified nanoparticles targeting CXCR4 for precision cancer therapy;Journal of Drug Targeting;2024-04-29

4. Liver fibrosis;Sinusoidal Cells in Liver Diseases;2024

5. Sinusoidal cell interactions—From soluble factors to exosomes;Sinusoidal Cells in Liver Diseases;2024